July 16, 2018 by Chain Drug Review
diabetes, Medicare, NACDS, pharmacists
Leading Headlines, Pharmacy
ARLINGTON, Va. – A National Association of Chain Drug Stores ) op-ed published by Morning Consult today describes the role of community pharmacy practice and of NACDS members’ philanthropic initiatives in helping to prevent and manage diabetes. “Two of the central areas where pharmacies and pharmacists have the greatest impact in diabetes are medication management and behavior change
June 26, 2018 by Chain Drug Review
American Diabetes Association, diabetes, Eli Lilly, Tom Hardy
Pharmacy, Supplier News
ORLANDO, Fla. — Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog. URLi is Lilly’s novel mealtime insulin currently in phase 3 development. The data was presented in
April 17, 2018 by Chain Drug Review
Boehringer Ingelheim, diabetes, Eli Lilly, Jardiance, kidney disease
Pharmacy, Supplier News
RIDGEFIELD, Conn. and INDIANAPOLIS — Boehringer Ingelheim and Eli Lilly and Co. yesterday announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney disease and the occurrence of cardiovascular death, in adults with established chronic kidney disease with and without diabetes. EMPA-KIDNEY will be independently conducted, analyzed and reported by the Medical
April 5, 2018 by Chain Drug Review
diabetes, Insulins VALyou Savings Program, Michelle Carnahan, Sanofi
Pharmacy, Supplier News
BRIDGEWATER, N.J. — Sanofi’s new Insulins VALyou Savings Program will seek to help lower out-of-pocket costs for people living with diabetes who otherwise would pay full retail price for Lantus or Admelog. This includes certain uninsured patients who don’t qualify for traditional patient assistance programs, in addition to some commercially insured patients with a high
June 27, 2017 by Brian Bossetta
diabetes, Eating Healthy with Diabetes, Hy-Vee Inc.
Leading Headlines, Pharmacy, Retail News
WEST DES MOINES, Iowa — Midwestern retailer Hy-Vee is enhancing its diabetes programs with Begin for Diabetes, a lifestyle management program designed for the unique set of health and nutrition challenges those dealing with the disease face. The program, which the company just launched, adds to Hy-Vee’s existing Begin and Begin 4 Kids programs. All three diabetes
April 12, 2016 by Chain Drug Review
aseptic nutritional shake, diabetes, Glucerna, Joseph Papa, Perrigo
Pharmacy, Supplier News
DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Abbott’s Glucerna aseptic nutritional shake for adults with diabetes. Perrigo said Tuesday that its product represents a first-to-market launch of an over-the-counter, private-brand equivalent to Glucerna. The company said its product is packaged and marketed as a store brand or retailer “own
August 28, 2015 by Chain Drug Review
Calibrium, diabetes, Mads Krogsgaard Thomsen, MB2, Novo Nordisk, obesity, Richard DiMarchi
Pharmacy, Supplier News
BAGSVAERD, Denmark — Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind. The Danish pharmaceutical company said Thursday that the acquisition will expand its portfolio of projects and intellectual property rights in the diabetes and obesity segments and help expand Novo Nordisk’s research presence
July 6, 2015 by John Schultz and Chain Drug Review
Adam Pellegrini, Balance Rewards for healthy choices, diabetes, digital health, Harry Leider, hypertension, medication adherence, Walgreens
Issue 07-06-2015, Issues, News
DEERFIELD, Ill. — Walgreen Co. says that its Balance Rewards for healthy choices (BRhc) program, which awards loyalty points for healthy behaviors and activities, is helping members lose weight and driving better medication adherence among participants with hypertension and/or diabetes. According to a new white paper and outcomes data the company released, active members who
May 27, 2015 by Chain Drug Review and Chain Drug Review
David Kendall, diabetes, Eli Lilly, first concentrated mealtime insulin analog, Humalog 200 units/ml KwikPen, Humalog U-200 KwikPen, Lilly Diabetes, Mike Mason
Pharmacy, Supplier News
INDIANAPOLIS — Eli Lilly and Co. has been cleared by the Food and Drug Administration to market the Humalog 200 units/ml KwikPen, which the company called the first concentrated mealtime insulin analog approved in the United States. Lilly said Wednesday that the Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml, U-200) is a prefilled pen
April 24, 2015 by Chain Drug Review and Chain Drug Review
diabetes, Nipro Diagnostics, Scott Verner, True Metrix Air Self-Monitoring blood glucose system
Supplier News
FORT LAUDERDALE, Fla. — Nipro Diagnostics Inc. has gained approval from the Food and Drug Administration for the True Metrix Air Self-Monitoring blood glucose system, which enables people with diabetes to test blood glucose and deliver data wirelessly to a smartphone. Nipro said Friday that the True Metrix Air will be available starting in the